KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Total Debt (2019 - 2025)

GoodRx Holdings' Total Debt history spans 7 years, with the latest figure at $488.3 million for Q4 2025.

  • For Q4 2025, Total Debt fell 0.7% year-over-year to $488.3 million; the TTM value through Dec 2025 reached $488.3 million, down 0.7%, while the annual FY2025 figure was $488.3 million, 0.7% down from the prior year.
  • Total Debt for Q4 2025 was $488.3 million at GoodRx Holdings, roughly flat from $489.1 million in the prior quarter.
  • Across five years, Total Debt topped out at $665.9 million in Q1 2021 and bottomed at $488.3 million in Q4 2025.
  • The 5-year median for Total Debt is $656.6 million (2023), against an average of $608.7 million.
  • The largest annual shift saw Total Debt dropped 0.35% in 2023 before it decreased 25.1% in 2024.
  • A 5-year view of Total Debt shows it stood at $662.9 million in 2021, then decreased by 0.61% to $658.8 million in 2022, then dropped by 0.35% to $656.5 million in 2023, then fell by 25.1% to $491.7 million in 2024, then decreased by 0.7% to $488.3 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Total Debt are $488.3 million (Q4 2025), $489.1 million (Q3 2025), and $490.0 million (Q2 2025).